erythromycin has been researched along with Moraxella Infections in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kasai, A; Nishiyama, H; Ogihara, S; Saito, R; Tanimichi, Y; Yamada, K | 1 |
| Derendorf, H; Rand, KH; Schmidt, S; Suvanakoot, U; Treyaprasert, W | 1 |
2 other study(ies) available for erythromycin and Moraxella Infections
| Article | Year |
|---|---|
Prevalence and molecular analysis of macrolide-resistant Moraxella catarrhalis clinical isolates in Japan, following emergence of the highly macrolide-resistant strain NSH1 in 2011.
Topics: Anti-Bacterial Agents; Azithromycin; Clarithromycin; Clindamycin; Drug Resistance, Multiple, Bacterial; Erythromycin; Japan; Microbial Sensitivity Tests; Moraxella catarrhalis; Moraxellaceae Infections; Mutation; RNA, Ribosomal, 23S | 2015 |
Pharmacokinetic/pharmacodynamic modeling of in vitro activity of azithromycin against four different bacterial strains.
Topics: Anti-Bacterial Agents; Azithromycin; Bacteria; Erythromycin; Haemophilus Infections; Haemophilus influenzae; Humans; In Vitro Techniques; Microbial Sensitivity Tests; Models, Biological; Moraxella catarrhalis; Moraxellaceae Infections; Penicillin Resistance; Pneumococcal Infections; Streptococcus pneumoniae | 2007 |